Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

A Dose-finding Trial With Lu-AG09222 in Adults With Migraine Who Have Not Been Helped by Prior Preventive Treatments

ClinicalTrials.gov ID: NCT06323928

Public ClinicalTrials.gov record NCT06323928. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 24, 2026, 10:41 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Interventional, Randomized, Double-blind, Parallel-group, Placebo-controlled, Dose-finding Trial of Lu AG09222 for the Prevention of Migraine in Participants With Unsuccessful Prior Preventive Treatments

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this trial is to determine which doses of Lu AG09222 are recommended to help prevent migraines. People who join this trial have already tried 1 to 4 other available medications to prevent their migraines, but these medications have not helped them.

Study identification

NCT ID
NCT06323928
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
H. Lundbeck A/S
Industry
Enrollment
874 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 1, 2024 (Actual)
Primary completion
Jan 16, 2026 (Actual)
Completion
Mar 16, 2026 (Actual)
Last update posted
Jun 12, 2026

2024 – 2026

United States locations

U.S. sites
28
U.S. states
12
U.S. cities
27
Facility City State ZIP Site status
Accel Research Sites Network - Neurology and Neurodiagnostic of Alabama Hoover Alabama 35244-5700 —
Profound Research - Neurology Center of Southern California Carlsbad California 92011 —
Neurology Center of North Orange County Fullerton California 92835 —
CenExel CNS Los Alamitos California 90720 —
ASCLEPES Research Centers Sherman Oaks California 91403 —
Ki Health Partners LLC DBA New England Institute for Clinical Research Stamford Connecticut 06905 —
K2 Medical Research - Winter Garden Clermont Florida 34711 —
Clinical Neuroscience Solutions, Inc. Jacksonville Florida 32256 —
K2 Medical Research, LLC - Maitland Maitland Florida 32751 —
Aqualane Clinical Research Naples Florida 34105 —
K2 Medical Research Tampa LLC Tampa Florida 33607 —
Premiere Research Institute Palm Beach West Palm Beach Florida 33407 —
Accellacare and McFarland Clinic Ames Iowa 50010 —
Clinical Research Professionals Chesterfield Missouri 63005 —
Healthcare Research Network Hazelwood Missouri 63042 —
Dent Neurosciences Research Center, Inc. Amherst New York 14226 —
North Suffolk Neurology, PC. Port Jefferson Station New York 11776 —
Accellacare of Cary - Cary Medical Group Cary North Carolina 27518 —
Headache Wellness Center Greensboro North Carolina 27405 —
Raleigh Medical Group Raleigh North Carolina 27609 —
M3 Wake Research, Inc Raleigh North Carolina 27612 —
Accellacare of Rocky Mount Rocky Mount North Carolina 27804 —
Triad Neurological Associates Winston-Salem North Carolina 27103 —
Accellacare of Charleston Mt. Pleasant South Carolina 29464 —
Internal Medicine and Pediatric Associates of Bristol, PC Bristol Tennessee 37620 —
Cedar Health Research, LLC Dallas Texas 75251 —
Mercury Clinical Research Sugar Land Texas 77478 —
MedStar Health - Neurology Clinic at McLean McLean Virginia 22101 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 92 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06323928, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 12, 2026 · Synced Oct 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT06323928 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →